Royalty Pharma to Announce Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025

Core Viewpoint - Royalty Pharma plc will report its fourth quarter and full year 2024 financial results on February 11, 2025, before U.S. markets open, followed by a conference call at 8:30 a.m. Eastern Time [1]. Company Overview - Royalty Pharma, founded in 1996, is the largest buyer of biopharmaceutical royalties and a key funder of innovation in the biopharmaceutical industry [3]. - The company collaborates with various entities, including academic institutions, research hospitals, non-profits, small and mid-cap biotechnology companies, and leading global pharmaceutical companies [3]. - Royalty Pharma's portfolio includes royalties on over 35 commercial products, such as Vertex's Trikafta, GSK's Trelegy, Roche's Evrysdi, and others, as well as 14 development-stage product candidates [3].